Management of warfarin in atrial fibrillation: views of health professionals, older patients and their carers

被引:42
作者
Bajorek, Beata V. [1 ]
Ogle, Susan J.
Duguid, Margaret J.
Shenfield, Gillian M.
Krass, Ines
机构
[1] Univ Sydney, Dept Pharm, Sydney, NSW 2006, Australia
[2] No Sydney Cent Coast Hlth, Sydney, NSW, Australia
[3] Royal N Shore Hosp, Sydney, NSW, Australia
关键词
D O I
10.5694/j.1326-5377.2007.tb00856.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify the views of health professionals, patients and their carers on strategies to improve the use and management of warfarin in older patients with atrial fibrillation. Design: Qualitative study based on analysis of group interviews. Setting: A major metropolitan teaching hospital, from 1 March to 30 April 2003. Participants: 14 patients (>= 65 years) with established atrial fibrillation and taking warfarin, three carers, 12 specialists, eight general practitioners, six community pharmacists, nine hospital pharmacists, and 11 nurses volunteered in response to flyers promoting the study. Results: Suggested strategies to improve warfarin management targeted support services for GPs and patients. Hospital-based clinicians felt that dissemination of trial evidence to GPs to support treatment recommendations is required, and that GPs need to enlist allied health professionals in the management of patients taking warfarin. GPs preferred access to practical advice from expert colleagues on the day-to-day management. Patients requested more information about warfarin therapy, as access to information is inadequate, particularly from primary sources (GPs, community pharmacists). Verbal and written information are equally important, but a single counselling session or supply of a booklet was viewed as inadequate. Participants identified various interventions for all levels of warfarin management; from the collective input, a framework for management strategies was developed. Conclusions: Health professionals and patients require more customised information to support warfarin use and management.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [31] Is warfarin really underused in patients with atrial fibrillation?
    Steven D. Weisbord
    Jeff Whittle
    Robert C. Brooks
    Journal of General Internal Medicine, 2001, 16 : 743 - 749
  • [32] Why is Warfarin Underutilized in Patients with Atrial Fibrillation?
    Greg C. Flaker
    John Schutz
    Journal of Interventional Cardiac Electrophysiology, 2004, 10 : 21 - 25
  • [33] The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
    Koroleva, Lyubov Yu.
    Kolesnichenko, Irina V.
    Nosov, Vladimir P.
    Zlobin, Maxim V.
    Abelevich, Dmitry I.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (05) : 553 - 557
  • [34] Why is warfarin underutilized in patients with atrial fibrillation?
    Flaker, GC
    Schutz, J
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2004, 10 (01) : 21 - 25
  • [35] Edoxaban versus Warfarin in patients with atrial fibrillation
    Meras Colunga, P.
    REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 346 - 346
  • [36] Is warfarin really underused in patients with atrial fibrillation?
    Weisbord, SD
    Whittle, J
    Brooks, RC
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (11) : 743 - 749
  • [37] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [38] Warfarin in CKD patients with atrial fibrillation Reply
    Keskar, Vaibhav
    McArthur, Eric
    Wald, Ron
    Harel, Ziv
    Zimmerman, Deborah
    Molnar, Amber
    Garg, Amit X.
    Ngan Lam
    McCallum, Megan K.
    Bota, Sarah E.
    Perl, Jeffrey
    Sood, Manish M.
    KIDNEY INTERNATIONAL, 2017, 92 (03) : 767 - 767
  • [39] The early status of warfarin management in patients with atrial fibrillation after catheter ablation
    Tang Lihong
    Xue Yu-Mei
    Wu Shu-Lin
    Deng Hai
    Huang Jun
    Zhan Xian-Zhang
    Fang Xian-Hong
    Liao Hong-Tao
    Wei Wei
    Liu Yang
    Liao Zi-Li
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C163 - C164
  • [40] PRESCRIPTION PATTERNS, ADHERENCE AND QUALITY OF MANAGEMENT OF WARFARIN IN CHINESE PATIENTS WITH ATRIAL FIBRILLATION
    Du, Xin
    HEART, 2013, 99 : E244 - E244